| C049325 | 1,2-dithiol-3-thione | 1,2-dithiol-3-thione results in decreased expression of CYP51 mRNA | 19162173 |
| C018406 | 1-(3-trifluoromethylphenyl)piperazine | 1-(3-trifluoromethylphenyl)piperazine results in increased expression of CYP51 mRNA | 26821219 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of CYP51 mRNA | 22698814 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | NR1I3 protein promotes the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of CYP51 mRNA] | 22698814 |
| C490166 | 1-(4-methoxyphenyl)piperazine | 1-(4-methoxyphenyl)piperazine results in increased expression of CYP51 mRNA | 26821219 |
| C055238 | 1-chloro-4-(2,2-dichloro-1-(4-chlorophenyl)ethenyl)-3-(methylsulfonyl)benzene | 1-chloro-4-(2,2-dichloro-1-(4-chlorophenyl)ethenyl)-3-(methylsulfonyl)benzene results in increased expression of CYP51 mRNA | 23333615 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of CYP51 mRNA | 30723492 |
| C078092 | 1-piperonylpiperazine | 1-piperonylpiperazine results in increased expression of CYP51 mRNA | 26821219 |
| C111118 | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of CYP51 mRNA | 19114083 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of CYP51 mRNA | 30722647 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of CYP51 mRNA | 28433925 |
| C016403 | 2,4-dinitrotoluene | 2,4-dinitrotoluene affects the expression of CYP51 mRNA | 21346803 |
| C023514 | 2,6-dinitrotoluene | 2,6-dinitrotoluene affects the expression of CYP51 mRNA | 21346803 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP51 mRNA | 23196670 |
| C008745 | 4,4'-bisphenol F | 4,4'-bisphenol F results in increased expression of CYP51 mRNA | 25576683 |
| C009505 | 4,4'-diaminodiphenylmethane | 4,4'-diaminodiphenylmethane results in increased expression of CYP51 mRNA | 18648102 |
| D015124 | 8-Bromo Cyclic Adenosine Monophosphate | [monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP51 mRNA | 18467523 |
| D015124 | 8-Bromo Cyclic Adenosine Monophosphate | [monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP51 protein | 18467523 |
| D015124 | 8-Bromo Cyclic Adenosine Monophosphate | naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP51 mRNA] | 18467523 |
| D015124 | 8-Bromo Cyclic Adenosine Monophosphate | naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP51 protein] | 18467523 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of CYP51 mRNA | 17562736 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of CYP51 mRNA | 29246445 |
| D000082 | Acetaminophen | PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of CYP51 mRNA] | 29246445 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of CYP51 mRNA | 18246545 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of CYP51 mRNA | 18246545 |
| C014949 | acetylhydrazine | acetylhydrazine results in increased expression of CYP51 mRNA | 15282401 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of CYP51 mRNA | 19770486 |
| C040534 | alpha-hexachlorocyclohexane | alpha-hexachlorocyclohexane results in increased expression of CYP51 mRNA | 17785943 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of CYP51 mRNA | 16483693 |
| C082410 | azalanstat | azalanstat binds to and results in decreased activity of CYP51 protein | 8161528 |
| C082410 | azalanstat | azalanstat results in decreased activity of CYP51 protein | 18467523 |
| D001507 | Beclomethasone | Beclomethasone results in increased expression of CYP51 mRNA | 23656298 |
| D001548 | Benzalkonium Compounds | Benzalkonium Compounds results in increased expression of CYP51 mRNA | 31199489 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of CYP51 mRNA | 19770486; 22228805; |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in decreased expression of CYP51 mRNA | 22234961 |
| D019324 | beta-Naphthoflavone | AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of CYP51 mRNA] | 22234961 |
| D019324 | beta-Naphthoflavone | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP51 mRNA | 18164116 |
| D001629 | Bezafibrate | Bezafibrate results in decreased expression of CYP51 mRNA | 17719200 |
| C006780 | bisphenol A | bisphenol A affects the expression of CYP51 mRNA | 21786754 |
| C006780 | bisphenol A | bisphenol A affects the expression of CYP51 mRNA | 30566610 |
| C006780 | bisphenol A | bisphenol A results in increased expression of CYP51 mRNA | 25270620 |
| C006780 | bisphenol A | [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of CYP51 mRNA | 30722647 |
| C006780 | bisphenol A | [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of CYP51 mRNA | 28433925 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of CYP51 mRNA | 30816183 |
| C006780 | bisphenol A | bisphenol A results in increased expression of CYP51 mRNA | 12075121 |
| C032036 | bromobenzene | bromobenzene results in decreased expression of CYP51 mRNA | 12628495 |
| C027561 | butylbenzyl phthalate | butylbenzyl phthalate results in decreased expression of CYP51 mRNA | 26472102 |
| D002087 | Butyrates | Butyrates results in decreased expression of CYP51 mRNA | 14674679 |
| C028031 | cadmium acetate | cadmium acetate affects the expression of CYP51 mRNA | 16249259 |
| D002251 | Carbon Tetrachloride | [Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of CYP51 mRNA | 30517762 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the expression of CYP51 mRNA | 15963342 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of CYP51 mRNA | 31150632 |
| C026690 | cerous chloride | cerous chloride affects the expression of CYP51 mRNA | 23139204 |
| D002737 | Chloroprene | Chloroprene results in decreased expression of CYP51 mRNA | 23125180 |
| D004390 | Chlorpyrifos | Chlorpyrifos results in increased expression of CYP51 mRNA | 21356183 |
| C074702 | chromium hexavalent ion | chromium hexavalent ion affects the expression of CYP51 mRNA | 28472532 |
| D002922 | Ciguatoxins | Ciguatoxins affects the expression of CYP51 mRNA | 18353800 |
| D002990 | Clobetasol | Clobetasol results in increased expression of CYP51 mRNA | 27462272 |
| C018021 | cobaltous chloride | cobaltous chloride results in decreased expression of CYP51 mRNA | 24612858 |
| D003042 | Cocaine | Cocaine results in decreased expression of CYP51 mRNA | 12629581 |
| D003300 | Copper | Copper results in decreased expression of CYP51 mRNA | 17205981 |
| D003300 | Copper | Copper results in decreased expression of CYP51 mRNA | 30556269 |
| D019327 | Copper Sulfate | Copper Sulfate results in decreased expression of CYP51 mRNA | 19789285 |
| D019327 | Copper Sulfate | Copper Sulfate results in increased expression of CYP51 mRNA | 19789285 |
| C030123 | coumarin | coumarin results in decreased expression of CYP51 mRNA | 18480146 |
| D016578 | Crack Cocaine | Crack Cocaine results in increased expression of CYP51 mRNA | 12629581 |
| D003471 | Cuprizone | Cuprizone results in decreased expression of CYP51 mRNA | 27523638 |
| D000242 | Cyclic AMP | Cyclic AMP results in increased expression of CYP51 mRNA | 25576683 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of CYP51 mRNA | 18172885 |
| C093628 | cyproconazole | cyproconazole affects the expression of CYP51 mRNA | 22045034 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of CYP51 mRNA] | 27941970 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of CYP51 mRNA | 17998272 |
| D003907 | Dexamethasone | Dexamethasone affects the expression of CYP51 mRNA | 15102944 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in increased expression of CYP51 mRNA | 17361019; 21266533; |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of CYP51 mRNA | 17379624; 21266533; 21745491; 26472102; |
| D004008 | Diclofenac | Diclofenac results in increased expression of CYP51 mRNA | 26934552 |
| D004041 | Dietary Fats | Dietary Fats affects the expression of CYP51 mRNA | 19680557 |
| D004041 | Dietary Fats | [Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP51 mRNA | 28433925; 30722647; |
| D004041 | Dietary Fats | [Dietary Fats co-treated with Tobacco Smoke Pollution] results in decreased activity of CYP51 protein | 29688711 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of CYP51 mRNA | 15238619; 19030233; 22609946; 30120929; |
| D004041 | Dietary Fats | [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of CYP51 mRNA | 30722647 |
| D019422 | Dietary Sucrose | [Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP51 mRNA | 28433925; 30722647; |
| D019422 | Dietary Sucrose | [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of CYP51 mRNA | 30722647 |
| D004051 | Diethylhexyl Phthalate | [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of CYP51 mRNA | 30722647 |
| D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in increased expression of CYP51 mRNA | 19850644 |
| D004051 | Diethylhexyl Phthalate | PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of CYP51 mRNA] | 19850644 |
| D004051 | Diethylhexyl Phthalate | [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of CYP51 mRNA | 28433925 |
| D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in decreased expression of CYP51 mRNA | 26472102 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of CYP51 mRNA | 24535843 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP51 mRNA | 18164116 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in decreased expression of CYP51 mRNA | 19638242 |
| C115058 | difenoconazole | difenoconazole results in increased expression of CYP51 mRNA | 29337257 |
| C115058 | difenoconazole | difenoconazole results in increased expression of CYP51 mRNA | 28263823 |
| D013196 | Dihydrotestosterone | Dihydrotestosterone results in increased expression of CYP51 mRNA | 29458080 |
| D013196 | Dihydrotestosterone | Dihydrotestosterone results in decreased expression of CYP51 mRNA | 29367455 |
| C034171 | di-n-pentyl phthalate | di-n-pentyl phthalate results in decreased expression of CYP51 mRNA | 26472102 |
| D004147 | Dioxins | Dioxins affects the expression of CYP51 mRNA | 20463971 |
| D004237 | Diuron | Diuron results in decreased expression of CYP51 mRNA | 21551480 |
| C012301 | domoic acid | domoic acid results in increased expression of CYP51 mRNA | 18936300 |
| D004726 | Endosulfan | Endosulfan affects the expression of CYP51 mRNA | 29391264 |
| D000431 | Ethanol | [Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of CYP51 mRNA | 30517762 |
| D000431 | Ethanol | Ethanol results in increased expression of CYP51 mRNA | 19167417; 30319688; |
| D000431 | Ethanol | [Fish Oils co-treated with Ethanol] results in increased expression of CYP51 mRNA | 17347304 |
| D000431 | Ethanol | Ethanol results in increased expression of CYP51 mRNA | 28069986 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of CYP51 mRNA | 16872691 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of CYP51 mRNA | 17351261 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of CYP51 mRNA | 17108234 |
| C024565 | ethylene dichloride | ethylene dichloride results in decreased expression of CYP51 mRNA | 28189721 |
| D005228 | Fatty Acids, Essential | Fatty Acids, Essential deficiency results in increased expression of CYP51 mRNA | 23333450 |
| D005228 | Fatty Acids, Essential | NR1H2 gene mutant form promotes the reaction [Fatty Acids, Essential deficiency results in increased expression of CYP51 mRNA] | 23333450 |
| D005228 | Fatty Acids, Essential | NR1H3 gene mutant form promotes the reaction [Fatty Acids, Essential deficiency results in increased expression of CYP51 mRNA] | 23333450 |
| C033789 | fenarimol | fenarimol results in increased expression of CYP51 mRNA | 29337257 |
| C033789 | fenarimol | fenarimol results in increased expression of CYP51 mRNA | 28970091 |
| D005395 | Fish Oils | [Fish Oils co-treated with Ethanol] results in increased expression of CYP51 mRNA | 17347304 |
| D005411 | Flame Retardants | Flame Retardants results in decreased expression of CYP51 mRNA | 18534652 |
| D005411 | Flame Retardants | Flame Retardants results in increased expression of CYP51 mRNA | 18534652 |
| C007738 | fluoranthene | fluoranthene results in decreased expression of CYP51 mRNA | 28329830 |
| C061365 | flusilazole | flusilazole results in decreased expression of CYP51 mRNA | 22382673 |
| C061365 | flusilazole | flusilazole results in increased expression of CYP51 mRNA | 22382673; 22664269; |
| C061365 | flusilazole | flusilazole affects the expression of CYP51 mRNA | 22634333 |
| C061365 | flusilazole | flusilazole results in increased expression of CYP51 mRNA | 21192963; 29337257; |
| C061365 | flusilazole | flusilazole results in increased expression of CYP51 mRNA | 22664269 |
| D005485 | Flutamide | Flutamide results in decreased expression of CYP51 mRNA | 24136188 |
| C039281 | furan | furan results in increased expression of CYP51 mRNA | 24183702 |
| D005944 | Glucosamine | Glucosamine results in increased expression of CYP51 mRNA | 17178593 |
| C004312 | glycidol | glycidol results in decreased expression of CYP51 mRNA | 24915197 |
| C089796 | hexabromocyclododecane | hexabromocyclododecane results in decreased expression of CYP51 mRNA | 18534652 |
| C089796 | hexabromocyclododecane | hexabromocyclododecane results in increased expression of CYP51 mRNA | 18534652 |
| D001556 | Hexachlorocyclohexane | Hexachlorocyclohexane results in increased expression of CYP51 mRNA | 17785943 |
| C029424 | hydrazine | hydrazine results in increased expression of CYP51 mRNA | 15282401 |
| D007213 | Indomethacin | Indomethacin results in increased expression of CYP51 mRNA | 28201806 |
| D007220 | Industrial Waste | Industrial Waste results in increased expression of CYP51 mRNA | 26055946 |
| D007654 | Ketoconazole | Ketoconazole results in increased expression of CYP51 mRNA | 29337257 |
| D007654 | Ketoconazole | Ketoconazole results in increased expression of CYP51 protein | 17966066 |
| D007654 | Ketoconazole | Ketoconazole results in increased activity of CYP51 protein | 12617470 |
| D007654 | Ketoconazole | [Ketoconazole results in increased activity of CYP51 protein] which results in increased abundance of Lanosterol | 12617470 |
| D007654 | Ketoconazole | Ketoconazole results in increased expression of CYP51 mRNA | 28263823 |
| C099406 | L 742694 | L 742694 affects the expression of CYP51 mRNA | 15102944 |
| D007810 | Lanosterol | [Ketoconazole results in increased activity of CYP51 protein] which results in increased abundance of Lanosterol | 12617470 |
| C017461 | lead nitrate | [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of CYP51 mRNA] | 22293356 |
| C017461 | lead nitrate | lead nitrate results in increased expression of CYP51 mRNA | 22293356 |
| C017461 | lead nitrate | lead nitrate results in increased expression of CYP51 mRNA | 15475176 |
| D000077339 | Leflunomide | Leflunomide results in increased expression of CYP51 mRNA | 24136188 |
| D064704 | Levofloxacin | Levofloxacin results in increased expression of CYP51 mRNA | 24136188 |
| D000077222 | Limonene | Limonene results in increased expression of CYP51 mRNA | 12815608 |
| D008095 | Lithocholic Acid | Lithocholic Acid results in decreased expression of CYP51 mRNA | 20359477 |
| D058185 | Magnetite Nanoparticles | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CYP51 mRNA | 21641980 |
| D058185 | Magnetite Nanoparticles | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CYP51 mRNA | 26378955 |
| D008701 | Methapyrilene | Methapyrilene results in increased expression of CYP51 mRNA | 30467583 |
| D008752 | Methylene Chloride | Methylene Chloride affects the expression of CYP51 mRNA | 28392392 |
| D008767 | Methylmercury Compounds | Methylmercury Compounds results in increased expression of CYP51 mRNA | 16966085 |
| D008825 | Miconazole | Miconazole results in increased expression of CYP51 mRNA | 27462272; 29337257; |
| C016599 | mono-(2-ethylhexyl)phthalate | mono-(2-ethylhexyl)phthalate results in decreased expression of CYP51 mRNA | 22087261 |
| C002373 | monobutyryl cyclic AMP | [monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP51 mRNA | 18467523 |
| C002373 | monobutyryl cyclic AMP | [monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP51 protein | 18467523 |
| C002373 | monobutyryl cyclic AMP | naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP51 mRNA] | 18467523 |
| C002373 | monobutyryl cyclic AMP | naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP51 protein] | 18467523 |
| D037742 | Nanotubes, Carbon | Nanotubes, Carbon analog results in decreased expression of CYP51 mRNA | 25620056 |
| D037742 | Nanotubes, Carbon | Nanotubes, Carbon analog results in increased expression of CYP51 mRNA | 25554681 |
| D037742 | Nanotubes, Carbon | Nanotubes, Carbon results in decreased expression of CYP51 mRNA | 25620056 |
| D037742 | Nanotubes, Carbon | Nanotubes, Carbon results in increased expression of CYP51 mRNA | 25554681 |
| C495860 | naphthol AS-E phosphate | naphthol AS-E phosphate inhibits the reaction [FSHB protein results in increased expression of CYP51 mRNA] | 18467523 |
| C495860 | naphthol AS-E phosphate | naphthol AS-E phosphate inhibits the reaction [FSHB protein results in increased expression of CYP51 protein] | 18467523 |
| C495860 | naphthol AS-E phosphate | naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP51 mRNA] | 18467523 |
| C495860 | naphthol AS-E phosphate | naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP51 protein] | 18467523 |
| C461488 | N-benzylpiperazine | N-benzylpiperazine results in increased expression of CYP51 mRNA | 26821219 |
| C028007 | nickel monoxide | nickel monoxide results in increased expression of CYP51 mRNA | 19167457 |
| C016340 | o,p'-DDT | o,p'-DDT affects the expression of CYP51 mRNA | 18925944 |
| D010100 | Oxygen | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYP51 mRNA | 30529165 |
| D010126 | Ozone | Ozone results in increased expression of CYP51 mRNA | 12763052 |
| D000073878 | Palm Oil | Palm Oil affects the expression of CYP51 mRNA | 19680557 |
| C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid affects the expression of CYP51 mRNA | 19429403 |
| C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in increased expression of CYP51 mRNA | 20936131 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid affects the expression of CYP51 mRNA | 19429403 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in decreased expression of CYP51 mRNA | 19162173 |
| D010634 | Phenobarbital | Phenobarbital affects the expression of CYP51 mRNA | 19136022 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of CYP51 mRNA | 19162173 |
| D010656 | Phenylephrine | Phenylephrine results in increased expression of CYP51 mRNA | 18158353 |
| D010705 | Phosgene | Phosgene affects the expression of CYP51 mRNA | 16300373 |
| D010840 | Phytosterols | APOE gene mutant form affects the reaction [Phytosterols results in increased expression of CYP51 mRNA] | 18155511 |
| C006253 | pirinixic acid | pirinixic acid affects the expression of CYP51 mRNA | 19136022 |
| C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CYP51 mRNA | 19710929 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of CYP51 mRNA | 18445702 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of CYP51 mRNA | 17950772; 20813756; 20936131; |
| C006253 | pirinixic acid | PPARA protein promotes the reaction [pirinixic acid results in increased expression of CYP51 mRNA] | 17950772 |
| D017035 | Pravastatin | Pravastatin results in increased expression of CYP51 mRNA | 27225895 |
| C045362 | prochloraz | prochloraz results in increased expression of CYP51 mRNA | 21470553 |
| D011374 | Progesterone | Progesterone results in increased expression of CYP51 mRNA | 23012394 |
| C045950 | propiconazole | propiconazole results in increased expression of CYP51 mRNA | 16730040; 17178688; 21278054; 25949234; 29337257; |
| C045950 | propiconazole | propiconazole results in decreased expression of CYP51 mRNA | 23339182 |
| C045950 | propiconazole | propiconazole results in increased expression of CYP51 mRNA | 28970091 |
| D011441 | Propylthiouracil | Propylthiouracil results in decreased expression of CYP51 mRNA | 24780913 |
| C550005 | prothioconazole | prothioconazole results in increased expression of CYP51 mRNA | 29337257 |
| D011718 | Pyrazinamide | Pyrazinamide results in increased expression of CYP51 mRNA | 22431067 |
| C031280 | pyrazole | pyrazole results in increased expression of CYP51 mRNA | 17945193 |
| C030984 | pyrene | pyrene results in decreased expression of CYP51 mRNA | 23656968 |
| C052785 | rebamipide | rebamipide results in increased expression of CYP51 mRNA | 18299717 |
| D000077185 | Resveratrol | Resveratrol results in increased expression of CYP51 protein | 25505154 |
| D012312 | Ritodrine | Ritodrine results in decreased expression of CYP51 mRNA | 23370008 |
| D019438 | Ritonavir | Ritonavir results in increased expression of CYP51 mRNA | 17719200 |
| D012402 | Rotenone | Rotenone results in decreased expression of CYP51 mRNA | 28374803 |
| C541923 | sandostatinLAR | sandostatinLAR results in decreased expression of CYP51 mRNA | 17210224 |
| D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of CYP51 mRNA | 29203145 |
| D012834 | Silver | Silver results in decreased expression of CYP51 mRNA | 27131904 |
| D019821 | Simvastatin | Simvastatin results in increased expression of CYP51 mRNA | 25055962 |
| C009277 | sodium arsenate | sodium arsenate results in decreased expression of CYP51 mRNA | 23922661 |
| C016104 | sodium bichromate | sodium bichromate results in decreased expression of CYP51 mRNA | 24612858 |
| D012967 | Sodium Dodecyl Sulfate | Sodium Dodecyl Sulfate results in decreased expression of CYP51 mRNA | 12815608 |
| D053260 | Soot | Soot results in increased expression of CYP51 mRNA | 22461453 |
| C075117 | squalestatin 1 | squalestatin 1 results in increased expression of CYP51 mRNA | 27225895 |
| D004113 | Succimer | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CYP51 mRNA | 21641980 |
| D004113 | Succimer | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CYP51 mRNA | 26378955 |
| C013698 | tallow | tallow affects the expression of CYP51 mRNA | 19680557 |
| D013629 | Tamoxifen | Tamoxifen affects the expression of CYP51 mRNA | 20937368 |
| C087114 | tebuconazole | tebuconazole results in increased expression of CYP51 mRNA | 29337257 |
| D013749 | Tetrachlorodibenzodioxin | [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of CYP51 mRNA | 30722647 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of CYP51 mRNA | 28433925 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP51 gene] | 28213091 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of CYP51 mRNA | 28213091; 28238261; 28922406; |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of CYP51 mRNA | 21215274 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP51 mRNA | 26232522 |
| D013752 | Tetracycline | Tetracycline results in increased expression of CYP51 mRNA | 16917069 |
| D013853 | Thioacetamide | Thioacetamide results in increased methylation of CYP51 promoter | 27914986 |
| C009495 | titanium dioxide | titanium dioxide results in decreased expression of CYP51 mRNA | 21513982 |
| C009495 | titanium dioxide | titanium dioxide results in increased expression of CYP51 mRNA | 23409001 |
| D014028 | Tobacco Smoke Pollution | [Dietary Fats co-treated with Tobacco Smoke Pollution] results in decreased activity of CYP51 protein | 29688711 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of CYP51 mRNA | 29545142 |
| D000077867 | Tolcapone | Tolcapone results in increased expression of CYP51 mRNA | 24136188 |
| D014050 | Toluene | Toluene affects the expression of CYP51 mRNA | 18653662 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of CYP51 mRNA | 20530235 |
| C032910 | triadimefon | triadimefon results in increased expression of CYP51 mRNA | 17178688; 25949234; 29337257; |
| C032910 | triadimefon | triadimefon results in increased expression of CYP51 mRNA | 17178689 |
| C015559 | trimellitic anhydride | trimellitic anhydride results in increased expression of CYP51 mRNA | 19042947 |
| C406224 | valdecoxib | valdecoxib results in increased expression of CYP51 mRNA | 24136188 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of CYP51 mRNA | 17292431; 17963808; |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of CYP51 mRNA | 22045034 |
| D014640 | Vancomycin | Vancomycin results in increased expression of CYP51 mRNA | 18930951 |
| D001335 | Vehicle Emissions | Vehicle Emissions affects the methylation of CYP51 gene | 25560391 |
| C025643 | vinclozolin | vinclozolin affects the expression of CYP51 mRNA | 19015723 |
| C025643 | vinclozolin | vinclozolin results in increased expression of CYP51 mRNA | 22570695; 23034163; |
| C029297 | vinylidene chloride | vinylidene chloride results in decreased expression of CYP51 mRNA | 26682919 |
| D015025 | Zearalenone | Zearalenone results in increased expression of CYP51 protein | 25058043 |